BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 10685333)

  • 1. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
    Waggoner W; Boots LR; Azziz R
    Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen-secreting adrenal adenomas.
    Danilowicz K; Albiger N; Vanegas M; Gómez RM; Cross G; Bruno OD
    Obstet Gynecol; 2002 Nov; 100(5 Pt 2):1099-102. PubMed ID: 12423821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of adrenal versus ovarian androgen ratio on signs and symptoms of polycystic ovarian syndrome.
    Köşüş N; Köşüş A; Kamalak Z; Hızlı D; Turhan NÖ
    Gynecol Endocrinol; 2012 Aug; 28(8):611-4. PubMed ID: 22296561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of pure testosterone-secreting adrenal adenoma in a postmenopausal elderly woman.
    Zhou WB; Chen N; Li CJ
    BMC Endocr Disord; 2019 Jan; 19(1):14. PubMed ID: 30674304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
    Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
    Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
    Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 21-Hydroxylase deficiency in female hyperandrogenism: screening and diagnosis.
    Azziz R; Zacur HA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):577-84. PubMed ID: 2547827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the ovary in the adrenal androgen excess of hyperandrogenic women.
    Azziz R; Rittmaster RS; Fox LM; Bradley EL; Potter HD; Boots LR
    Fertil Steril; 1998 May; 69(5):851-9. PubMed ID: 9591492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmenopausal hyperandrogenism.
    Yoldemir T
    Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postmenopausal hyperandrogenism due to an ovarian sex cord-stromal tumour causing elevated dehydroepiandrosterone sulphate: a case report.
    Sumanatilleke M; de Silva NL; Ranaweera G; Appuhamy C; Karunaratne K; de Silva MVC
    BMC Womens Health; 2022 Jul; 22(1):297. PubMed ID: 35843927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
    Chen M; Zhou W; Zhang Z; Zou Y; Li C
    Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
    Hirschberg AL
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex steroids in androgen-secreting adrenocortical tumors: clinical and hormonal features in comparison with non-tumoral causes of androgen excess.
    d'Alva CB; Abiven-Lepage G; Viallon V; Groussin L; Dugue MA; Bertagna X; Bertherat J
    Eur J Endocrinol; 2008 Nov; 159(5):641-7. PubMed ID: 18708437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.
    Adefris M; Fekadu E
    J Med Case Rep; 2017 Aug; 11(1):242. PubMed ID: 28851436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.
    Coskun A; Ercan O; Arikan DC; Özer A; Kilinc M; Kiran G; Kostu B
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):167-71. PubMed ID: 21041013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal androgen excess in hyperandrogenism: relation to age and body mass.
    Morán C; Knochenhauer E; Boots LR; Azziz R
    Fertil Steril; 1999 Apr; 71(4):671-4. PubMed ID: 10202877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low leptin level in an obese hyperandrogenic woman--potential marker for androgen-secreting tumor.
    Cvijovic G; Yamashita SA; Micic D; Kendereski A; Sumarac-Dumanovic M; Zoric S; Popovic V
    Gynecol Endocrinol; 2007 Feb; 23(2):112-6. PubMed ID: 17454162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.